Eosinophilic Esophagitis
Links to articles and abstracts or articles or abstracts excerpted or reproduced in their entirety:
- Pediatric Patients Have Shorter Lansoprazole Half-Life Than Previously Reported
- Pharmacokinetics of orally administered omeprazole in children
- Proton Pump Inhibitor Prescribing Patterns in Newborns and Infants
- There are Notes to bring to your Doctor of the three articles above: Peer Reviewed Article Support for Increased Dosing (adult levels or greater) of PPI’s
- Stability of Partial Doses of Omeprazole-Sodium Bicarbonate Oral Suspension
- Upper Esophageal pH Monitoring of Children With the Bravo pH Capsule
- Burnett JE, Balkin ER. Stability and viscosity of a flavored omeprazole oral suspension for pediatric use. American Journal of Health-Systems Pharmacy 2006; 63:2240-2247.
- Flavored Lansoprazole in Pediatric GERD
- Flavored Lansoprazole Suspension (ChocoBase™) in Pediatric Gastroesophageal Reflux Disease
- Outcome of Reflux Therapy On Pediatric Chronic Sinusitis
- The Stability of Lansoprazole and Omeprazole in ChocoBase™
- Use of Flavored Lansoprazole or Omeprazole Suspensions in Pediatric GERD
- Gastroesophageal Reflux Management Guidance for the Pediatrician (2013 AAP Clinical Report
References:
- Proton Pump Inhibitor Utilization Patterns in Infants. Journal of Pediatric Gastroenterology and Nutrition 2007: 45;421-427
- Heyman M, Zhang W, Huang B, Y C., Amer F, Winter H. Pharmacokinetics and pharmacodynamics of lansoprazole in children 13 to 24 months old with Gastroesophageal Reflux Disease. Pediatric Gastroenterology and Nutrition 2007, 44, (1), 35-40.
- Phillips JO, Burnett J, Siddiqi S, Bothwell M. Pediatric patients have shorter lansoprazole half life than previously reported. American Journal of Gastroenterology 2007; 102, (s2), S548. (click for abstract or download poster)
- Zhao J, Li J, Hamer-Maansson J, Andersson T, Fulmer R, Illueca M, Lundborg P. Pharmacokinetic properties of esomeprazole in children aged 1 to 11 years with symptoms of gastroesophageal reflux disease: a randomized, open-label study. Clinical Therapeutics 2006, 28, (11), 1868-76.
- Freston J, Pilmer B, Chiu Y, Wang Q, Stolle J, Griffin J, Lee C. Evaluation of the pharmacokinetics and pharmacodynamics of intravenous lansoprazole. Aliment Pharmacol Ther 2004, 19, 1111-1122.
- Gremse D, Winter H, Tolia V, Gunasekaran T, Pan W, Karol M, Chiu Y, Pilmer B, Book L. Pharmacokinetics and pharmacodynamics of lansoprazole in children with Gastroesophageal Reflux Disease. Journal of Pediatric Gastroenterology and Nutrition 2002, 35, (November/December), S319-S326.
- Gunasekaran T, Gupta S, Gremse D, Karol M, Pan W, Chiu Y, Keith R, Fitzgerald J. Lansoprazole in adolescents with Gastroesophageal Reflux Disease: pharmacokinetics, pharmacodynamics, symptom relief efficacy, and tolerability. Journal of Pediatric Gastroenterology and Nutrition 2002, 35, (November/December), S327-S335.
- Mainz D, Borner K, Koeppe P, Kotwas J, Lode H. Pharmacokinetics of lansoprazole, amoxicillin, and clarithromycin after simultaneous and single administration. Journal of Antimicrobial Chemotherapy 2002, 50, 699-706.
- Tran A, Rey E, Pons G, Pariente-Khayat A, d’Athis P, Sallerin V, Dupont C. Pharmacokinetic-pharmacodynamic study of oral lansoprazole in children. Clin Pharmacol Ther 2002, 71, 359-67.
- Ammon S, Treiber G, Kees F, Klotz U. Influence of age on the steady state disposition of drugs commonly used for the eradication of Helicobacter pylori. Aliment Pharmacol Ther 2000, 14, 759-766.
- Phillips JO, Bettag ME, Parsons DS, Wilder B, Metzler MH. Use of flavored lansoprazole or omeprazole suspensions in pediatric GERD. [Abstract A1292] Gastroenterology 2000; 118: 5904.
- Phillips JO, Parsons DS, Fitts SW. Flavored lansoprazole suspension in pediatric GERD. [Abstract] Journal of Pediatric Gastroenterology and Nutrition 2000; 31:S181. [Abstract No. 707].
- Flouvat B, Delhotal-Landes B, Cournot A, Dellatolas F. Single and multiple dose pharmacokinetics of lansoprazole in elderly subjects. Br J Clin Pharmacol 1993, 36, 467-469.
- Gunasekaran TS, Hassall EG. Efficacy and safety of omeprazole for severe gastroesophageal reflux in children. Journal of Pediatrics 1993; 123:148-154.
- Hussein Z, Granneman G, Mukherjee D, Samara E, Hogan D, Koss M, Isenberg J. Age-related differences in the pharmacokinetics and pharmacodynamics of lansoprazole. Br J Clin Pharmacol 1993, 36, 391-398